Comparison between tryptophan methoxyindole and kynurenine metabolic pathways in normal and preterm neonates and in neonates with acute fetal distress

European Journal of Endocrinology

Volumn 139, Issue 1, 1998, Pages 89-95

  Munoz Hoyos A ^a,c   Molina Carballo, A ^a   Macias M ^b   Rodriguez Cabezas T ^a   Martin Medina E ^a   Narbona Lopez E ^a   Valenzuela Ruiz, A ^a   Acuna Castroviejo D ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENINE; MELATONIN; TRYPTOPHAN;

ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED STUDY; FETUS DISTRESS; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; STRESS; TRYPTOPHAN METABOLISM;

ACUTE DISEASE; CIRCADIAN RHYTHM; FEMALE; FETAL BLOOD; FETAL DISTRESS; HUMANS; INDOLES; INFANT, NEWBORN; INFANT, PREMATURE; KYNURENINE; MALE; MELATONIN; REFERENCE VALUES; TRYPTOPHAN; UMBILICAL ARTERIES; UMBILICAL VEINS;

EID: 0031858369     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390089     Document Type: Article

References (43)

1. Auricchio S, Quagliarello E & Rubino A. Interrelation of tryptophan and nicotinic acid in man during the first month of life. Nature 1960 186 639-640.
2. Snyderman SE, Boyer A, Phansalkar SV & Holt LE. Essential aminoacids requirements of infants. American Journal of Disease in Childhood 1961 102 163-167.
3. Gholson RK, Nishizuka Y, Ichiyama A, Kaway H, Nakamura S & Hayaisi O. Tryptophan metabolism in man. New intermediates in catabolism of tryptophan in mammalian liver. Journal of Biological Chemistry 1963 237 2043-2045.
4. Anton-Tay F. Melatonin: effects on brain function. Advances in Psychopharmacology 1974 11 315-324.
5. Molina-Carballo A, Acuña-Castroviejo D, Rodríguez-Cabezas T & Muñoz-Hoyos A. Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentration in children. Journal of Pineal Research 1994 16 1-9.
6. Molina-Carballo A, Muñoz-Hoyos A, Rodríguez Cabezas T & Acuña-Castroviejo D. Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children. Psychiatry Research 1994 52 273-283.
7. Molina-Carballo A, Muñoz-Hoyos A, Reiter RJ, Sánchez-Porte M, Moreno-Madrid F, Rufo-Campos M, Molina-Font JA & Acuña-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsivant therapy in a child with severe myoclonic epilepsy: two years' experience. Journal of Pineal Research 1997 23 97-105.
8. Reiter RJ, Blask DE, Talbot JA & Barnett MP. Nature and the time course of seizures associated with surgical removal of the pineal gland from parathyroidectomized rats. Experimental Neurology 1973 38 386-397.
9. Albertson TE, Peterson SL, Stark LC & Lakin ML. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 1981 20 61-66.
10. Champney TH & Peterson SL Circadian, seasonal, pineal and melatonin influences on epilepsy. In Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications pp 477-494. Eds HS Yu & RJ Reiter. London: CRC Press, 1993.
11. Acuña-Castroviejo D, Lowenstein PR, Rosenstein RE & Cardinali DP. Diurnal variations of benzodiazepine binding in rat cerebral cortex: disruption by pinealectomy. Journal of Pineal Research 1986 3 101-109.
12. Acuña-Castroviejo D, Rosenstein RE, Romeo HE & Cardinali DP Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealeclomy or melatonin administration to rats. Neuroendocrinology 1986 43 24-31.
13. Acuña-Castroviejo D, Castillo JL, Fernández B, Gomar MD & Del Aguila CM. Modulation by pineal gland of ouabain high-affinity binding sites in rat cerebral cortex. American Journal of Physiology 1992 262 R698-R706.
14. 3H]flunitrazepam binding. NeuroReport 1993 4 987-990.
15. 3H-flunitrazepam receptor binding in the rat cerebral cortex. Neuroendocrinology 1994 60 252-260.
16. Giusti P, Lipartiti M, Franceschini D, Schiavo N, Floreani M & Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB Journal 1996 10 891-896.
17. Castillo-Romero JL, Vives-Montero F & Acuña-Castroviejo D. Pineal modulation of the rat caudate-putamen spontaneous neuronal activity: roles of melatonin and vasotocin. Journal of Pineal Research 1993 15 147-152.
18. Escames G, Arauzo M, Acuña-Castroviejo D & Vives F. Melatonin-dopamine interaction in the striatal projection area of the sensorimotor cortex in the rat. NeuroReport 1996 7 597-600.
19. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuña-Castroviejo D & Guerrero JM. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. Journal of Pineal Research 1996 20 205-210.
20. Maestroni GJM, Conti A & Pierpaoli W. Melatonin, stress, and the immune system. In Pineal Research Reviews, pp 203-226. Ed RJ Reiter. New York: Alan R. Liss. 1989.
21. Muñoz A, Rodríguez T, Molina A, Martínez JJ, Ruiz C & Acuña Castroviejo. D. Melatonin concentration in the umbilical artery and vein in human preterm and term neonates and neonates with acute fetal distress. Journal of Pineal Research 1992 13 184-191.
22. Fernández B, Montera A, Del Aguila CM, Malde JL, Castillo JL & Acuña-Castroviejo D. Relationship between pineal activity and the hypothalamus-hypophysis-gonadal axis in human pregnancy and cord blood of term infants. I. Melatonin and steroid hormones. Steroid Biochemistry (Life Science Advanced) 1992 11 89-96.
23. Muñoz-Hoyos A, Jaldo-Alba F, Molina-Carballo A, Rodríguez-Cabezas T, Molina-Font JA & Acuña-Castroviejo D. Absence of plasma melatonin circadian rhythm during the first 72 hours of life in human infants. Journal of Clinical Endocrinology and Metababolism 1993 77 699-703.
24. Attanasio A, Rager K & Gupta D. Ontogeny of circadian rhythmicity for melatonin, serotonin and N-acetyl-serotonin in humans. Journal of Pineal Research 1986 3 251-256.
25. Jaldo-Alba F, Muñoz-Hoyos A, Molina-Carballo A, Molina-Font JA & Acuña-Castroviejo D. Light deprivation increases plasma levels of melatonin during the first 72 h of life in human infants. Acta Endocrinologica 1993 129 442-445.
26. Meldrum B. Neurotransmitter amino acids in epilepsy. Electroencephalography and Clinical Neurophysiology 1987 39 191-199.
27. 2+ decrease assessed in the hippocampus by brain dialysis. Brain Research 1988 454 289-297.
28. Lapin IP. Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships. Neuropharmacology 1982 21 1227-1233.
29. Lapin IP. Effects of kynurenine and quinolinic acid on the action of convulsants in mice. Pharmacology Biochemistry and Behavior 1980 13 17-20.
30. Foster AC, Vezzani A, French ED & Schwarcz R. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neuroscience Letters 1984 48 273-278.
31. Beninger RJ, Jhamandas K, Boegman RJ & El-Defawy SR. Kynurenic acid-induced protection on neurochemical and behavioural deficits produced by quinolinic acid injections into the nucleus basalis of rats. Neuroscience Letters 1986 68 317-321.
32. Fernánden B, Malde JL, Montero D & Acuña D. Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. Journal of Steroid Biochemistry 1990 35 257-262.
33. Coppini D, Benassi CA & Montorsi M. Quantitative determination of tryptophan metabolites (via kynurenina) in biological fluids. Clinical Chemistry 1959 5 391-401.
34. Muñoz-Hoyos A, Molina-Carballo A, Rodríguez-Cabezas T, Uberos-Fernández J, Ruiz-Cosano C & Acuña-Castroviejo D. Relationship between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures. Clinical Endocrinology 1997 47 667-678.
35. Freer DE, Statland BE & Sher G. Quantification of disaturated phosphatidylcholine and phosphatidylglycerol in amniotic fluid by fluorescence diminution: methodology and clinical results. Clinical Chemistry 1979 25 960-968.
36. Altman KI & Greenbard O. Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction. Journal of Clinical Investigation 1966 45 1525-1534.
37. Takeuchi F & Shibata Y. Kynurenine metabolism in vitamin B6 deficient rat liver after tryptophan injection. Biochemical Journal 1984 220 693-699.
38. Careddu P, Apollonio T & Mereu T. Metabolismo del triptofano nel neonato. Eliminatione urinaria di chinurenina e suci derivati dopo carico L-triptofano. Minerva Pediatrica 1961 13 1631-1636.
39. Muñoz-Hoyos A, Amorós-Rodríguez I, Molina-Carballo A, Uberos-Fernández J & Acuña-Castroviejo D. Pineal response after piridoxine test in children. Journal of Neural Transmission 1996 103 833-842.
40. Irwin M, Belendiuk K, McCloskey K & Freedman DX. Tryptophan metabolism in children with attentional deficit disorder. American Journal of Psychiatry 1981 138 1082-1085.
41. Anderson GM, Hoder EL, Shaywitz BA & Cohen DJ. Neurotransmitter precursors and metabolites in CSF of human neonates. Developmental Medicine and Child Neurology 1985 27 207-214.
42. Lapin IP. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids. Journal of Neural Transmission 1983 56 177-185.
43. Acuña-Castroviejo D, Escames G, Macías M, Muǹoz-Hoyos A, Molina-Carballo A, Montes R & Vives F. Cell protective role of melatonin in brain. Journal of Pineal Research 1995 19 57-63.